Immediate Impact
37 standout
Citing Papers
AXL signaling in cancer: from molecular insights to targeted therapies
2025 Standout
Myeloid-derived suppressor cells (MDSCs) in the tumor microenvironment and their targeting in cancer therapy
2025 Standout
Works of Robin Meng being referenced
Therapeutic Opportunities with Pharmacological Inhibition of CD38 with Isatuximab
2019
Vandetanib in patients with inoperable hepatocellular carcinoma: A phase II, randomized, double-blind, placebo-controlled study
2012
Author Peers
| Author | Last Decade | Papers | Cites | ||||
|---|---|---|---|---|---|---|---|
| Robin Meng | 115 | 71 | 6 | 65 | 9 | 228 | |
| Nazir Jamal | 100 | 71 | 5 | 90 | 9 | 267 | |
| David Stroncek | 77 | 57 | 5 | 86 | 10 | 256 | |
| Matthew Lumley | 89 | 142 | 20 | 31 | 9 | 297 | |
| N C Lea | 89 | 82 | 21 | 131 | 11 | 273 | |
| Muqddas Tariq | 69 | 4 | 3 | 87 | 11 | 235 | |
| Joy Schaefer | 120 | 46 | 2 | 64 | 6 | 289 | |
| Heinz-Josef Lenz | 177 | 11 | 3 | 142 | 9 | 289 | |
| Kaoru Takase-Minegishi | 58 | 67 | 1 | 29 | 11 | 271 | |
| Muriel Duluc | 147 | 22 | 11 | 102 | 11 | 224 | |
| Clive Buckle | 178 | 123 | 3 | 156 | 9 | 276 |
All Works
Loading papers...